The Virginia (VA) AIDS Drug Assistance Program (ADAP) provides access to life-saving medications for the treatment of HIV and related illnesses for low-income clients through the provision of medications or through assistance with insurance premiums and medication co-payments. The program is primarily supported with federal Ryan White (RW) Treatment Extension Act Part B grant funding, which is distributed by a formula based on living HIV and AIDS cases to all states and territories in the United States. VA ADAP provides insurance cost support or directly purchased medications through four service options: Direct ADAP, the Medicare Part D Assistance Program (MPAP), the Insurance Continuation Assistance Program (ICAP) and the Health Insurance Marketplace Assistance Program (HIMAP).
Clinical Support and Policy Development
In 1996, an ADAP Advisory Committee was created. The committee is comprised of HIV/AIDS medical providers, a pharmacist, and consumers. The committee advises VDH on changes to the formulary, changes in eligibility criteria, adherence issues, and educational concerns. The committee reviews data on ADAP utilization and assess budgetary implications of trends and program changes.
For more information about the committee, please see the ADAP Advisory Committee Scope.
ADAP Enrollment Numbers*
|Medicare Part D Assistance Program (MPAP)||584|
|Insurance Continuation Assistance Program||603|
|Health Insurance Marketplace Assistance Program (HIMAP, clients in ACA)||3,240|
Hepatitis C/HIV Co-Infected Treatment Assistance Program Enrollment Numbers*
|Number of clients that have accessed program||88|
|Number of clients that have completed treatment||76|
|Number of clients in treatment||6|
Questions or comments?
Medication Eligibility Hotline 1-855-362-0658
*Enrollment numbers as of November 2017